EW vs RAND · P/E 47, rev $1.39B vs $30.7M cap
Edwards Lifesciences Corp (EW) versus Rand Capital Corp (RAND) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Rand Capital Corp (RAND) is a asset management company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
RAND does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. RAND currently screens at market cap $30.7M.
Not investment advice. Open the EW and RAND stock pages for the full models.
Not investment advice.